Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Holders of 5% or more of VVOS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vivos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| V-Co Investors 3 LLC | 13D | 19.90%2.70M shares | New | Apr 2, 20261 filing | Apr 2, 2026 | SEC |
| V-CO Investors LLC | 13D | 19.90%1.34M shares | +10.00 ppfrom 9.90% | Dec 20, 20242 filings | Jun 16, 2025 | SEC |
| Luo Dawei | 13G | 8.52%572.0K shares | New | Jul 14, 20251 filing | Jul 14, 2025 | SEC |
| Armistice Capital, LLC | 13G | 8.27%1.12M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Vivos Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 202611:05 AM ET | Armistice Capital, LLCand 1 other | 13G | 8.27%1.12M shares | New | Mar 31, 2026 | SEC |
| Apr 2, 20266:32 PM ET | V-Co Investors 3 LLCand 4 others | 13D | 19.90%2.70M shares | New | Mar 31, 2026 | SEC |
| Jul 14, 20251:36 PM ET | Luo Dawei | 13G | 8.52%572.0K shares | New | Jul 8, 2025 | SEC |
| Jun 16, 20257:57 PM ET | V-CO Investors LLCand 3 others | 13D | 19.90%1.34M shares | +10.00 ppfrom 9.90% | Jun 9, 2025 | SEC |
| Dec 30, 20245:39 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%297.3K shares | NewBelow 5% | Dec 22, 2024 | SEC |
| Dec 20, 20243:17 PM ET | V-CO Investors LLCand 2 others | 13G | 9.90%514.5K shares | New | Dec 17, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vivos Therapeutics, Inc. shares.
No Form 144 notices for Vivos Therapeutics, Inc. are on file.